The excluded experimental groups were 12a and 12b (Cheng et al. [36]; animals were APP/PS1 mutants), 01b (Gatson et al. [45]; mice were treated with resveratrol), 02b (Goodus et al. [37]; mice had LIF± genotype), 20b (Maynard et al. [50]; animals were Sarm1-KO mutants), 18 and 19 (Mouzon et al. [57] and Mouzon et al. [51]; animals were hTau mutants), 14b (Namjoshi et al. [63]; animals were treated with androgenic–anabolic steroids), and 10b (Tu et al, [59]; animals had mild ventriculomegaly). The gene discussed is SARM1; the disease is Ventriculomegaly.